Evidence map›Paper›PMID 42851610›Full record

ArticleJournal of orthopaedic case reports2026

Delayed Metachronous Multicentric Giant Cell Tumor of Bone after a 16-Year Disease-Free Interval: A Case Report.

Dilip Kumar Sankhwar, Puneet Yadav, Asit Ranjan Mridha, Jaiben George, Vivek Shankar, Venkatesan Sampath Kumar

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dilip Kumar SankhwarDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.
Puneet YadavDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.
Asit Ranjan MridhaDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Jaiben GeorgeDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.
Vivek ShankarDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.
Venkatesan Sampath KumarDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multicentric giant cell tumor (GCT) of bone is rare and usually occurs synchronously or within a few years of the primary lesion. Delayed metachronous presentation is exceedingly uncommon. Case Report: We present the case of a 48-year-old man with progressive left hip pain 16 years after wide resection and endoprosthetic reconstruction for GCT of the proximal right humerus. Imaging demonstrated well-defined lytic lesions involving the bilateral proximal femur, left iliac bones, with cortical breach in the periacetabular region and right iliac bone. Whole-body positron emission tomography computed tomography revealed no additional skeletal lesions or pulmonary metastases, and core needle biopsy confirmed GCT. Metabolic evaluation, including serum parathyroid hormone levels, was normal, excluding hyperparathyroidism-related brown tumors. Given the multicentric involvement of the bilateral pelvis and proximal femur, the anatomically complex periarticular location of the lesions, and the substantial morbidity associated with extensive surgical resection and reconstruction, a non-operative treatment strategy was considered more appropriate. The patient was therefore treated with six intravenous zoledronic acid infusions at monthly intervals. Conclusion: There is achieved complete pain relief, returned to unrestricted functional activity, and demonstrated radiological stabilization with progressive sclerosis and no disease progression at 4-year follow-up. This case highlights the unpredictable biological behavior of GCT, the possibility of very late metachronous multicentric disease, and the potential role of bisphosphonate monotherapy as a limb-preserving treatment option in carefully selected patients.

Indexed as

bisphosphonatesGiant cell tumor of bonemetachronousmulticentriczoledronic acid

Identifiers

PMID42851610
PMCPMC13646563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.